Patent Yard Sign in
Canadian application, no grantCanada

Cytokine production inhibitors, triazepine compounds, and intermediates thereof

CA 2258053 A1 · Owner: Yamamoto, Yoshihisa · Inventors: Nakamura, Takeshi; Shindo, Masanori; Yamamoto, Yoshihisa

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Cytokine production inhibitors containing compounds represented by general formula (I), novel triazepine compounds and intermediates for producing these triazepine compounds. The compounds (I) inhibit the production of cytokines such as IL-6, TNF-.alpha. IL-8, IFN.gamma. IL-2 and GM-CSF and are useful as cytokine production inhibitors and antiinflammatory drugs. In formula (I) R1 , represents aryl or heteroaryl; B represents formula (a) or (b) (wherein R2 , represents hydrogen, hydroxy halogeno, etc.; R4 represents hydrogen or halogeno, or R2 and R4 may together form carbonyl; R3 represents lower alkoxy cycloalkyl, aryl, heteroaryl, -X-Y {wherein X represents -(CH2)m- -CO-, -, COCH2-, …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 11, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 11, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 11, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 11, 1997
GrantedNo grant recorded
Term endedJune 11, 2017
Patent numberCA 2258053 A1
Classification (IPC)C07D487/04 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedJune 11, 1997Term endedJune 11, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.